| Rebecca Newton, CCC/SLP | |
|
106 Gover St, Somerset, KY 42501-3332 | |
| (606) 679-8331 | |
| Not Available |
| Full Name | Rebecca Newton |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 106 Gover St, Somerset, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295188100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 140433 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Newton, CCC/SLP 106 Gover St, Somerset, KY 42501-3332 Ph: (606) 679-8331 | Rebecca Newton, CCC/SLP 106 Gover St, Somerset, KY 42501-3332 Ph: (606) 679-8331 |
News Archive
In patients undergoing hip replacement surgery, using a special wound catheter to infuse local anesthetic directly into the hip joint provides significant and lasting improvements in postoperative pain control, reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Recent research by Sandra Rieger, Ph.D., of the MDI Biological Laboratory identifying the underlying mechanisms of peripheral neuropathy, or nerve damage, has raised the prospect that drug therapies can be developed for the treatment of this condition, which causes pain, numbness and/or tingling in the hands and feet. The research was published March 28 in the Proceedings of the National Academy of Sciences.
A review of nearly 28,000 emergency department records shows less than 2% of patients diagnosed with COVID-19 suffered an ischemic stroke but those who did had an increased risk of requiring long-term care after hospital discharge.
In a new study, published recently on the bioRxiv preprint server, researchers isolated a nanobody that potently neutralizes SARS-CoV-2, including the B.1.351 variant, and cross-neutralizes SARS-CoV. They demonstrated the therapeutic potential of the nanobody in a human ACE2 (angiotensin-converting enzyme) transgenic mouse model.
› Verified 6 days ago
Mrs. Tamara B Cranfill, CCC/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 353 Bogle St, Suite 203, Somerset, KY 42503 Phone: 606-679-1761 Fax: 606-678-0971 | |
Allison Kathryn Parrott, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tower Cir, Somerset, KY 42503 Phone: 606-416-5139 | |
Dr. Sue Ann Losey, ED. D, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 208 Allen Dr, Somerset, KY 42503 Phone: 606-679-2250 | |
Mackenzie Flynn Epperson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tower Cir, Somerset, KY 42503 Phone: 606-416-5139 Fax: 606-416-5239 | |
Alisha Spinks, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 303 Second St, Somerset, KY 42501 Phone: 606-677-1166 | |
Brittany Gaines, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 303 Second St, Somerset, KY 42501 Phone: 606-677-1166 | |
Ginger Lee Davis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Norfleet Dr, Somerset, KY 42501 Phone: 606-678-5104 |